Colorectal dysplasia in inflammatory bowel disease: A clinicopathologic perspective

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 3, 2014, Pages 359-367

  Rutter, Matthew D ^a,b,c   Riddell, Robert H ^d,e  

^a UNIVERSITY HOSPITAL OF NORTH TEES   (United Kingdom)

^b DURHAM UNIVERSITY   (United Kingdom)

^c Northern Region Endoscopy Group   (United Kingdom)

^d MOUNT SINAI HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Colonoscopy; Colorectal Cancer; Dysplasia; Inflammatory Bowel Disease; Surveillance

Indexed keywords

COLONOSCOPY; COLORECTAL CANCER; DYSPLASIA; INFLAMMATORY BOWEL DISEASE; SURVEILLANCE;

COLONOSCOPY; COLORECTAL NEOPLASMS; HUMANS; INFLAMMATORY BOWEL DISEASES; METAPLASIA;

EID: 84893917565     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.05.033     Document Type: Article

References (57)

1. Sada M., Igarashi M., Yoshizawa S., et al. Dye spraying and magnifying endoscopy for dysplasia and cancer surveillance in ulcerative colitis. Dis Colon Rectum 2004, 47:1816-1823.
2. Riddell R.H., Goldman H., Ransohoff D.F., et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983, 14:931-968.
3. Morson B.C., Pang L.S. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 1967, 8:423-434.
4. Rubin C.E., Haggitt R.C., Burmer G.C., et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992, 103:1611-1620.
5. Eaden J.A., Ward B.A., Mayberry J.F. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc 2000, 51:123-128.
6. Kiesslich R., Fritsch J., Holtmann M., et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003, 124:880-888.
7. Rutter M.D., Saunders B.P., Schofield G., et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004, 53:256-260.
8. Kiesslich R., Goetz M., Lammersdorf K., et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology 2007, 132:874-882.
9. Dekker E., van den Broek F.J., Reitsma J.B., et al. Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy 2007, 39:216-221.
10. van den Broek F.J., Fockens P., van Eeden S., et al. Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions. Gut 2008, 57:1083-1089.
11. Marion J.F., Waye J.D., Present D.H., et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol 2008, 103:2342-2349.
12. Matsumoto T., Nakamura S., Jo Y., et al. Chromoscopy might improve diagnostic accuracy in cancer surveillance for ulcerative colitis. Am J Gastroenterol 2003, 98:1827-1833.
13. van den Broek F.J., Fockens P., van Eeden S., et al. Narrow-band imaging versus high-definition endoscopy for the diagnosis of neoplasia in ulcerative colitis. Endoscopy 2011, 43:108-115.
14. Hlavaty T., Huorka M., Koller T., et al. Colorectal cancer screening in patients with ulcerative and Crohn's colitis with use of colonoscopy, chromoendoscopy and confocal endomicroscopy. Eur J Gastroenterol Hepatol 2011, 23:680-689.
15. Ignjatovic A., East J.E., Subramanian V., et al. Narrow band imaging for detection of dysplasia in colitis: a randomized controlled trial. Am J Gastroenterol 2012, 107:885-890.
16. Rutter M.D., Saunders B.P., Wilkinson K.H., et al. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc 2004, 60:334-339.
17. Barclay R.L., Vicari J.J., Doughty A.S., et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. NEngl J Med 2006, 355:2533-2541.
18. Froehlich F., Wietlisbach V., Gonvers J.J., et al. Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study. Gastrointest Endosc 2005, 61:378-384.
19. Toruner M., Harewood G.C., Loftus E.V., et al. Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:428-434.
20. East J.E., Bassett P., Arebi N., et al. Dynamic patient position changes during colonoscope withdrawal increase adenoma detection: a randomized, crossover trial. Gastrointest Endosc 2011, 73:456-463.
21. Corte C., Dahlenburg L., Selby W., et al. Hyoscine butylbromide administered at the cecum increases polyp detection: a randomized double-blind placebo-controlled trial. Endoscopy 2012, 44:917-922.
22. de Brouwer E.J., Arbouw M.E., van der Zwet W.C., et al. Hyoscine N-butylbromide does not improve polyp detection during colonoscopy: a double-blind, randomized, placebo-controlled, clinical trial. Gastrointest Endosc 2012, 75:835-840.
23. Subramanian V., Ramappa V., Telakis E., et al. Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease. Inflamm Bowel Dis 2013, 19:350-355.
24. Kudo S., Hirota S., Nakajima T., et al. Colorectal tumours and pit pattern. JClin Pathol 1994, 47:880-885.
25. Davies J., Burke D., Olliver J.R., et al. Methylene blue but not indigo carmine causes DNA damage to colonocytes invitro and invivo at concentrations used in clinical chromoendoscopy. Gut 2007, 56:155-156.
26. Hurlstone D.P., Sanders D.S., Lobo A.J., et al. Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy 2005, 37:1186-1192.
27. Subramanian V., Mannath J., Ragunath K., et al. Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther 2011, 33:304-312.
28. Cairns S.R., Scholefield J.H., Steele R.J., et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010, 59:666-689.
29. Pellisé M., López-Cerón M., Rodríguez de Miguel C., et al. Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: a prospective, randomized, crossover study. Gastrointest Endosc 2011, 74:840-848.
30. Vieth M., Behrens H., Stolte M. Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment. Gut 2006, 55:1151-1155.
31. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 2003, 58(Suppl):S3-S43.
32. Bernstein C.N., Shanahan F., Weinstein W.M. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?. Lancet 1994, 343:71-74.
33. Connell W.R., Lennard-Jones J.E., Williams C.B., et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994, 107:934-944.
34. Jess T., Loftus E.V., Velayos F.S., et al. Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Inflamm Bowel Dis 2006, 12:669-676.
35. Dixon M.F., Brown L.J., Gilmour H.M., et al. Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology 1988, 13:385-397.
36. Curvers W.L., ten Kate F.J., Krishnadath K.K., et al. Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated. Am J Gastroenterol 2010, 105:1523-1530.
37. Blackstone M.O., Riddell R.H., Rogers B.H., et al. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981, 80:366-374.
38. Butt J.H., Konishi F., Morson B.C., et al. Macroscopic lesions in dysplasia and carcinoma complicating ulcerative colitis. Dig Dis Sci 1983, 28:18-26.
39. Schlemper R.J., Riddell R.H., Kato Y., et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000, 47:251-255.
40. Bernstein C.N. ALMs versus DALMs in ulcerative colitis: polypectomy or colectomy?. Gastroenterology 1999, 117:1488-1492.
41. Torres C., Antonioli D., Odze R.D. Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients. Am J Surg Pathol 1998, 22:275-284.
42. Odze R.D., Farraye F.A., Hecht J.L., et al. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol 2004, 2:534-541.
43. Rubin P.H., Friedman S., Harpaz N., et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 1999, 117:1295-1300.
44. Kisiel J.B., Loftus E.V., Harmsen W.S., et al. Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy. Inflamm Bowel Dis 2012, 18:226-235.
45. Pino M.S., Mino-Kenudson M., Wildemore B.M., et al. Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas. JMol Diagn 2009, 11:238-247.
46. Walsh M.D., Buchanan D.D., Pearson S.A., et al. Immunohistochemical testing of conventional adenomas for loss of expression of mismatch repair proteins in Lynch syndrome mutation carriers: a case series from the Australasian site of the colon cancer family registry. Mod Pathol 2012, 25:722-730.
47. Srivastava A., Redston M., Farraye F.A., et al. Hyperplastic/serrated polyposis in inflammatory bowel disease: a case series of a previously undescribed entity. Am J Surg Pathol 2008, 32:296-303.
48. Rubio C.A. Serrated neoplasias and de novo carcinomas in ulcerative colitis: a histological study in colectomy specimens. JGastroenterol Hepatol 2007, 22:1024-1031.
49. Montgomery E., Bronner M.P., Goldblum J.R., et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 2001, 32:368-378.
50. Rubio C.A., Johansson C., Slezak P., et al. Villous dysplasia. An ominous histologic sign in colitic patients. Dis Colon Rectum 1984, 27:283-287.
51. Huang Q., Fukami N., Kashida H., et al. Interobserver and intra-observer consistency in the endoscopic assessment of colonic pit patterns. Gastrointest Endosc 2004, 60:520-526.
52. Hurlstone D.P., Thomson M., Brown S., et al. Confocal endomicroscopy in ulcerative colitis: differentiating dysplasia-associated lesional mass and adenoma-like mass. Clin Gastroenterol Hepatol 2007, 5:1235-1241.
53. Chiba T., Marusawa H., Ushijima T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology 2012, 143:550-563.
54. Foersch S., Waldner M.J., Neurath M.F. Colitis and colorectal cancer. Dig Dis 2012, 30:469-476.
55. Jiang W., Shadrach B., Carver P., et al. Histomorphologic and molecular features of pouch and peripouch adenocarcinoma: a comparison with ulcerative colitis-associated adenocarcinoma. Am J Surg Pathol 2012, 36:1385-1394.
56. Shivakumar B.M., Kumar B.L., Bhat G., et al. Molecular alterations in colitis-associated colorectal neoplasia: study from a low prevalence area using magnifying chromo colonoscopy. JCrohns Colitis 2012, 6:647-654.
57. Kisiel J.B., Yab T.C., Nazer Hussain F.T., et al. Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2013, 37:546-554.